CARBOPLATIN AND PEMETREXED FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - OVERALL SURVIVAL AND TOXICITY

被引：0
|
作者：
Andersen, R. [1 ]
Mellemgaard, A. [1 ]
机构：
[1] Herlev Univ Hosp, DK-2730 Herlev, Denmark
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [1] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [2] RESPONSE RATES TO CARBOPLATIN AND PEMETREXED IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - A SINGLE CENTRE AUDIT
    Talbot, Toby L. J.
    Collinson, Matthew P.
    Buscombe, Charlotte
    Pascoe, Susan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1210 - S1210
  • [3] An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer
    Afzal, Muhammad Zubair
    Dragnev, Konstantin H.
    Shirai, Keisuke
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [4] Hospitalization and Survival of Medicare Patients Treated With Carboplatin Plus Paclitaxel or Pemetrexed for Metastatic, Non-squamous, Non-Small Cell Lung Cancer
    Brooks, Gabriel A.
    Austin, Andrea M.
    Uno, Hajime
    Dragnev, Konstantin H.
    Tosteson, Anna N. A.
    Schrag, Deborah
    [J]. JAMA NETWORK OPEN, 2018, 1 (06)
  • [5] A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer
    Afzal, Muhammad Zubair
    Dragnev, Konstantin
    Shirai, Keisuke
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3575 - 3584
  • [6] A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
    Verma, S.
    Malik, P. S.
    Kalra, K.
    Singh, V.
    Kumar, S.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Gupta, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S130 - S131
  • [7] Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer
    Zhang, Liang
    Ou, Wei
    Liu, Qianwen
    Li, Ning
    Liu, Li
    Wang, Siyu
    [J]. THORACIC CANCER, 2014, 5 (01) : 50 - 56
  • [8] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    [J]. LUNG CANCER, 2019, 135 : 104 - 109
  • [9] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer
    Paz-Ares, Luis G.
    Zimmermann, Annamaria
    Ciuleanu, Tudor
    Bunn, Paul A.
    Antonio, Belen San
    Denne, Jonathan
    Iturria, Nancy
    John, William
    Scagliotti, Giorgio V.
    [J]. LUNG CANCER, 2017, 104 : 45 - 51
12345